154 related articles for article (PubMed ID: 6153637)
1. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
[TBL] [Abstract][Full Text] [Related]
2. Ribonuclease-sensitive ribosomal vaccines.
Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
[TBL] [Abstract][Full Text] [Related]
3. RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.
Antonissen AC; Lemmens PJ; Gonggrijp R; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1985; 51(2):227-40. PubMed ID: 2412492
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Volleberg MP; Lemmens PJ; van Boven CP
Infect Immun; 1981 Mar; 31(3):896-905. PubMed ID: 6785242
[TBL] [Abstract][Full Text] [Related]
5. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
Gonggrijp R; Mullers WJ; van Boven CP
Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
[TBL] [Abstract][Full Text] [Related]
6. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
Gonggrijp R; Mullers WJ; van Boven CP
Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
[TBL] [Abstract][Full Text] [Related]
7. Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromide.
Antonissen AC; Lemmens PJ; van den Bosch JF; van Boven CP
Antonie Van Leeuwenhoek; 1986; 52(1):75-84. PubMed ID: 2425734
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
Lieberman MM
Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
[TBL] [Abstract][Full Text] [Related]
9. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
Phillips M; Rimler RB
Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
[TBL] [Abstract][Full Text] [Related]
10. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
Venneman MR; Bigley NJ
J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
Johnson W
Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
[TBL] [Abstract][Full Text] [Related]
12. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
Fumarola D; Panaro A; Palma R; Mazzone A
G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
[TBL] [Abstract][Full Text] [Related]
13. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
Riottot MM; Fournier JM
Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
[TBL] [Abstract][Full Text] [Related]
14. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
Youmans AS; Youmans GP
J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
[TBL] [Abstract][Full Text] [Related]
15. Isolation and properties of an RNA fraction present in Brucella culture supernatants.
Corbel MJ; Brewer RA
J Hyg (Lond); 1980 Apr; 84(2):223-36. PubMed ID: 6153668
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
Tewari RP; Lynn M; Birnbaum AJ; Solotorovsky M
Infect Immun; 1978 Jan; 19(1):58-65. PubMed ID: 304844
[TBL] [Abstract][Full Text] [Related]
17. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L
Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896
[TBL] [Abstract][Full Text] [Related]
18. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
Mates A; Zand P
J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
[TBL] [Abstract][Full Text] [Related]
19. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
Lieberman MM; Frank WJ
J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
[TBL] [Abstract][Full Text] [Related]
20. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
